Optimal Treatment of Chronic Pain Syndrome Caused by Musculoskeletal Disorders in the Elderly

D.M. Holynska, O.H. Holynska, I.B. Kalmakhelidze, A.V. Nagits


The paper shows the effectiveness and safety of combined use of Infulgan and Latren for the treatment of chronic pain syndrome caused by degenerative-dystrophic diseases of the musculoskeletal system in geriatric patients. The proposed scheme enables to minimize the use of invasive treatment and to achieve the desired results using medium therapeutic doses without the risk of complications from cardiovascular and digestive system.


chronic pain syndrome; degenerative-dystrophic diseases of the musculoskeletal system; Infulgan; Latren


Насонов Е.Л. Нестероидные противовоспалительные препараты: проблемы безопасности лечения // Consilium medicum. — 1999. — Т. 1. — № 5.

Насонов Е.Л. Болевой синдром при патологии опорно-двигательного аппарата // Врач. — 2002. — № 4.

Лабезник Л.Б., Дроздов В.Н. Заболевания органов пищеварения у пожилых. — М.: Анахарис, 2003.

Ревматология. Национальное руководство / Под ред. Е.Л. Насонова, В.А. Насоновой. — М.: ГЭОТАР-Медиа, 2008.

Яхно Н.Н. Боль. — Медпресс-информ, 2009.

Prescott L. Paracetamol: past, present and future // Am. J. Therap. — 2000.

Hermann M. Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs // Curr. Rheumatol. Rep. — 2009. — 11 (1).

Smith H. Potential Analgesic Mechanisms of Acetaminophen // Pain Physician. — 2009. — 12.

Mazer M., Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management // J. Med. Toxicol. — 2008. — 4 (1).

Day R., Graham G., Whelton A. The position of paracetamol in the world of analgesics // Am. J. Therap. — 2000.

Copyright (c) 2016 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2018


   Seo анализ сайта